REGN
38
-2
DOV
65
-4
WYNN
36
-5
SLB
52
-3
DE
42
3
SCHW
62
-2
MUR
44
-3
HCA
48
-2
DRI
50
-3
KLAC
38
-6
TJX
62
-2
DG
8
-2
PFE
14
-7
A
37
-2
HIG
66
2
XEL
67
2
TXN
43
-5
MTB
65
-2
SEE
53
3
WHR
65
-5
REGN
38
-2
DOV
65
-4
WYNN
36
-5
SLB
52
-3
DE
42
3
SCHW
62
-2
MUR
44
-3
HCA
48
-2
DRI
50
-3
KLAC
38
-6
TJX
62
-2
DG
8
-2
PFE
14
-7
A
37
-2
HIG
66
2
XEL
67
2
TXN
43
-5
MTB
65
-2
SEE
53
3
WHR
65
-5
Financhill
Back

ClearBridge Energy Midstream Opportunity Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
77

EMO
ClearBridge Energy Midstream Opportunity Fund

Last Price:
47.65
Seasonality Move:
3.79%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
77
ClearBridge Energy Midstream Opportunity Fund (EMO) is a Buy

Is ClearBridge Energy Midstream Opportunity Fund a Buy, Sell or Hold?

  • The current ClearBridge Energy Midstream Opportunity Fund [EMO] share price is $47.75. The Score for EMO is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • EMO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EMO Stock Price Chart

What is ClearBridge Energy Midstream Opportunity Fund's stock price today?

  • The ClearBridge Energy Midstream Opportunity Fund share price today is $47.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EMO is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EMO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.15 Buy
Relative Strength Index (14 RSI): 76.75 Buy
Chaikin Money Flow: 44223 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.09 - 46.15) Buy
Bollinger Bands (100): (39.65 - 43.87) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EMO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.71 Buy
20-day SMA: 44.84 Buy
50-day SMA: 43.22 Buy
200-day SMA: 40.85 Buy
8-day EMA: 46.48 Buy
20-day EMA: 45.23 Buy
50-day EMA: 43.66 Buy
200-day EMA: 40.44 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ClearBridge Energy Midstream Opportunity Fund Earnings Growth & EMO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ClearBridge Energy Midstream Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):